Niosome-Based Anticancer Therapies

Daulat Haleem Khan, Muhammad Yasir Ali, Muhammad Asim Farooq, Muhammad Ali Syed, Azhar Rasul, Shazia Anwer Bukhari, Sevki Adem, Maria Manan

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Niosomes are the non-ionic self-assembled bilayer vesicles stabilized with cholesterol with or without charge imparting agents. The niosomes can load hydrophilic and hydrophobic drugs. Niosomes are more stable and economical than liposomes. Niosomes have been used to load different types of drugs, i.e., anti-inflammatory, antivirals, antimicrobials, anticancer, etc., the niosomes have the capacity to increase the solubility of the poorly water-soluble drugs soluble. Among these, anticancer drugs are the best candidates to be loaded in niosomes. Many anticancer drugs are poorly water-soluble, resulting in low bioavailability and more toxicity. Niosomes show high entrapment efficiencies with increased solubility, bioavailability, and increased antiproliferative with the least toxicity of the drugs. Niosomes are the best nanocarrier for the delivery of all types of drugs, especially cytotoxic drugs.

Original languageEnglish
Title of host publicationCancer Targeting Therapies
Subtitle of host publicationConventional and Advanced Perspectives
PublisherCRC Press
Pages169-185
Number of pages17
ISBN (Electronic)9781000982930
ISBN (Print)9781032426259
DOIs
StatePublished - 1 Jan 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2024 selection and editorial matter, Muhammad Yasir Ali, Shazia Anwer Bukhari; individual chapters, the contributors.

ASJC Scopus subject areas

  • General Medicine
  • General Pharmacology, Toxicology and Pharmaceutics

Fingerprint

Dive into the research topics of 'Niosome-Based Anticancer Therapies'. Together they form a unique fingerprint.

Cite this